Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease

被引:0
|
作者
Alcalay, Roy N. [1 ]
Mejia-Santana, Helen [1 ]
Tang, Ming Xin [1 ,3 ]
Rosado, Llency [1 ]
Verbitsky, Miguel [3 ]
Kisselev, Sergey [3 ]
Ross, Barbara M. [3 ]
Louis, Elan D. [1 ,3 ,4 ,6 ]
Comella, Cynthia L. [12 ]
Colcher, Amy [16 ]
Jennings, Danna [14 ]
Nance, Martha A. [17 ]
Bressman, Susan [8 ,9 ]
Scott, William K. [18 ]
Tanner, Caroline [21 ]
Mickel, Susan F. [20 ]
Andrews, Howard F. [10 ]
Waters, Cheryl H. [1 ]
Fahn, Stanley [1 ]
Cote, Lucien J. [4 ]
Frucht, Steven J. [1 ]
Ford, Blair [1 ]
Rezak, Michael [11 ,13 ]
Novak, Kevin [11 ,13 ]
Friedman, Joseph H. [22 ,23 ]
Pfeiffer, Ronald [24 ]
Marsh, Laura [25 ,26 ]
Hiner, Bradley [19 ]
Siderowf, Andrew [15 ]
Caccappolo, Elise [3 ]
Ottman, Ruth [4 ,6 ]
Clark, Lorraine N. [2 ,3 ,5 ]
Marder, Karen S. [1 ,3 ,4 ,7 ]
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
[3] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[4] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA
[5] Columbia Univ, Coll Phys & Surg, Ctr Human Genet, New York, NY 10032 USA
[6] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[7] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA
[8] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[9] Albert Einstein Coll Med, Beth Israel Med Ctr, Alan & Barbara Mirken Dept Neurol, Bronx, NY 10467 USA
[10] Albert Einstein Coll Med, Data Coordinating Ctr, New York State Psychiat Inst, Bronx, NY 10467 USA
[11] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA
[12] Rush Univ, Dept Neurol, Movement Disorder Sect, Chicago, IL 60612 USA
[13] NorthShore Univ HealthSyst, Dept Neurol, Evanston, IL USA
[14] Inst Neurodegenerat Disorders, New Haven, CT USA
[15] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA
[16] Univ Penn Hlth Syst, Parkinsons Dis & Movement Disorders Ctr, Penn Hosp, Philadelphia, PA USA
[17] Park Nicollet Clin, Struthers Parkinsons Ctr, Golden Valley, MN USA
[18] Univ Miami, Miller Sch Med, Dept Human Genet, Miami Inst Human Genom,Dr John T Macdonald Fdn, Miami, FL 33136 USA
[19] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[20] Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA
[21] Parkinsons Inst, Sunnyvale, CA USA
[22] Parkinsons Dis & Movement Disorders Ctr NeuroHlth, Warwick, England
[23] Brown Univ, Warren Alpert Sch Med, Dept Clin Neurosci, Providence, RI 02912 USA
[24] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Neurol, Memphis, TN 38163 USA
[25] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci & Neurol & Neurol Sci, Baltimore, MD USA
[26] Johns Hopkins Univ, Morris K Udall Parkinsons Dis Res Ctr Excellence, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
TREMOR-DOMINANT PARKINSONISM; LEWY BODIES; MUTATION; DEMENTIA; GENE; SUBTYPE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the motor phenotype of LRRK2 G2019S mutation carriers. LRRK2 mutation carriers were previously reported to manifest the tremor dominant motor phenotype, which has been associated with slower motor progression and less cognitive impairment compared with the postural instability and gait difficulty (PIGD) phenotype. Design: Cross-sectional observational study. Setting: Thirteen movement disorders centers. Participants: Nine hundred twenty-five early-onset Parkinson disease cases defined as age at onset younger than 51 years. Main Outcome Measures: LRRK2 mutation status and Parkinson disease motor phenotype: tremor dominant or PIGD. Demographic information, family history of Parkinson disease, and the Unified Parkinson's Disease Rating Scale score were collected on all participants. DNA samples were genotyped for LRRK2 mutations (G2019S, I2020T, R1441C, and Y1699C). Logistic regression was used to examine associations of G2019S mutation status with motor phenotype adjusting for disease duration, Ashkenazi Jewish ancestry, levodopa dose, and family history of Parkinson disease. Results: Thirty-four cases (3.7%) (14 previously reported) were G2019S carriers. No other mutations were found. Carriers were more likely to be Ashkenazi Jewish (55.9% vs 11.9%; P < .001) but did not significantly differ in any other demographic or disease characteristics. Carriers had a lower tremor score (P=.03) and were more likely to have a PIGD phenotype (92.3% vs 58.9%; P=.003). The association of the G2019S mutation with PIGD phenotype remained after controlling for disease duration and Ashkenazi Jewish ancestry (odds ratio, 17.7; P<.001). Conclusion: Early-onset Parkinson disease G2019S LRRK2 carriers are more likely to manifest the PIGD phenotype, which may have implications for disease course.
引用
收藏
页码:1517 / 1522
页数:6
相关论文
共 50 条
  • [1] Motor phenotype of LRRK2 G2019S carriers in early onset PD
    Alcalay, R.
    Clark, L.
    Mejia-Santana, H.
    Tang, M.
    Rosado, L.
    Louis, E.
    Comella, C.
    Colcher, A.
    Jennings, D.
    Nance, M.
    Bressman, S.
    Scott, W.
    Tanner, C.
    Mickel, S.
    Andrews, H.
    Waters, C.
    Fahn, S.
    Ross, B.
    Cote, L.
    Frucht, S.
    Rezak, M.
    Ford, B.
    Novak, K.
    Friedman, J.
    Pfeiffer, R.
    Marsh, L.
    Caccappolo, E.
    Hiner, B.
    Siderowf, A.
    Ottman, R.
    Marder, K.
    MOVEMENT DISORDERS, 2009, 24 : S134 - S134
  • [2] The natural history of Parkinson's disease in LRRK2 G2019S carriers
    Kmiecik, M.
    Coker, D.
    Heilbron, K.
    Aslibekyan, S.
    Shelton, J.
    Cannon, P.
    Norcliffe-Kaufmann, L.
    MOVEMENT DISORDERS, 2023, 38 : S497 - S497
  • [3] Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease
    Alcalay, Roy N.
    Mejia-Santana, Helen
    Mirelman, Anat
    Saunders-Pullman, Rachel
    Raymond, Deborah
    Palmese, Christina
    Caccappolo, Elise
    Ozelius, Laurie
    Orr-Urtreger, Avi
    Clark, Lorraine
    Giladi, Nir
    Bressman, Susan
    Marder, Karen
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (02) : 106 - 110
  • [4] Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
    Marras, C.
    Schuele, B.
    Munhoz, R. P.
    Rogaeva, E.
    Langston, J. W.
    Kasten, M.
    Meaney, C.
    Klein, C.
    Wadia, P. M.
    Lim, S. -Y.
    Chuang, R. S. -I.
    Zadikof, C.
    Steeves, T.
    Prakash, K. M.
    de Bie, R. M. A.
    Adeli, G.
    Thomsen, T.
    Johansen, K. K.
    Teive, H. A.
    Asante, A.
    Reginold, W.
    Lang, A. E.
    NEUROLOGY, 2011, 77 (04) : 325 - 333
  • [5] Demographic and Clinical Characteristics of LRRK2 G2019S Carriers in Early Onset PD
    Alcalay, Roy N.
    Clark, Lorraine N.
    Mejia-Santana, Helen
    Tang, Ming
    Rosado, Llency E.
    Louis, Elan
    Comella, Cynthia
    Colcher, Amy
    Jennings, Danna
    Nance, Martha
    Bressman, Susan
    Scott, William K.
    Tanner, Caroline
    Mickel, Susan
    Andrews, Howard
    Waters, Cheryl
    Fahn, Stanley
    Ross, Barbara M.
    Cote, Lucien J.
    Frucht, Steven
    Rezak, Michael
    Ford, Blair
    Novak, Kevin
    Friedman, Joseph
    Pfeiffer, Ronald
    Marsh, Laura
    Caccappolo, Elise A.
    Hiner, Bradley
    Siderowf, Andrew
    Ottman, Ruth
    Marder, Karen
    NEUROLOGY, 2009, 72 (11) : A389 - A389
  • [6] Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
    Gunzler, Steven A.
    Riley, David E.
    Chen, Shu G.
    Tatsuoka, Curtis M.
    Johnson, William M.
    Mieyal, John J.
    Walter, Ellen M.
    Whitney, Christina M.
    Feng, I. Jung
    Owusu-Dapaah, Harry
    Mittal, Shivam O.
    Wilson-Delfosse, Amy L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 388 : 203 - 207
  • [7] Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations
    Alcalay, Roy N.
    Mirelman, Anat
    Saunders-Pullman, Rachel
    Tang, Ming-X
    Mejia Santana, Helen
    Raymond, Deborah
    Roos, Ernest
    Orbe-Reilly, Martha
    Gurevich, Tanya
    Bar Shira, Anat
    Weisz, Mali Gana
    Yasinovsky, Kira
    Zalis, Maayan
    Thaler, Avner
    Deik, Andres
    Barrett, Matthew James
    Cabassa, Jose
    Groves, Mark
    Hunt, Ann L.
    Lubarr, Naomi
    San Luciano, Marta
    Miravite, Joan
    Palmese, Christina
    Sachdev, Rivka
    Sarva, Harini
    Severt, Lawrence
    Shanker, Vicki
    Swan, Matthew Carrington
    Soto-Valencia, Jeannie
    Johannes, Brooke
    Ortega, Robert
    Fahn, Stanley
    Cote, Lucien
    Waters, Cheryl
    Mazzoni, Pietro
    Ford, Blair
    Louis, Elan
    Levy, Oren
    Rosado, Llency
    Ruiz, Diana
    Dorovski, Tsvyatko
    Pauciulo, Michael
    Nichols, William
    Orr-Urtreger, Avi
    Ozelius, Laurie
    Clark, Lorraine
    Giladi, Nir
    Bressman, Susan
    Marder, Karen S.
    MOVEMENT DISORDERS, 2013, 28 (14) : 1966 - 1971
  • [8] LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic
    Ben Romdhan, Sawssan
    Farhat, Nouha
    Nasri, Amina
    Lesage, Suzanne
    Hdiji, Olfa
    Ben Djebara, Mouna
    Landoulsi, Zied
    Stevanin, Giovanni
    Brice, Alexis
    Damak, Mariem
    Gouider, Riadh
    Mhiri, Chokri
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (05): : 425 - 431
  • [9] Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s disease
    Marta Soto
    Manel Fernández
    Paloma Bravo
    Sara Lahoz
    Alicia Garrido
    Antonio Sánchez-Rodríguez
    María Rivera-Sánchez
    María Sierra
    Paula Melón
    Ana Roig-García
    Anna Naito
    Bradford Casey
    Jordi Camps
    Eduardo Tolosa
    María-José Martí
    Jon Infante
    Mario Ezquerra
    Rubén Fernández-Santiago
    npj Parkinson's Disease, 9
  • [10] Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation
    Riboldi, Giulietta Maria
    Palma, Jose-Alberto
    Cortes, Etty
    Iida, Megan A.
    Sikder, Tamjeed
    Henderson, Brooklyn
    Raj, Towfique
    Walker, Ruth H.
    Crary, John F.
    Kaufmann, Horacio
    Frucht, Steven
    MOVEMENT DISORDERS, 2019, 34 (07) : 1080 - 1082